Agilent Technologies consensus picture, shares trade steadily on the NYSE
Published on 06/30/2026 at 11:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 11:22.
Agilent Technologies (US00846U1016) starts Tuesday with a focus on how analysts view the stock and where the shares trade. The company is listed on the NYSE, giving it a presence in one of the world’s most watched equity benchmarks.
What analysts currently expect
Agilent Technologies is followed by a broad group of sell-side analysts who publish regular ratings and price targets for the stock. Typically, larger US industrial and healthcare names of this size see coverage from houses such as Goldman Sachs, Morgan Stanley and UBS.
For a company in analytical instruments and life-science tools, the consensus often centers on mid-single-digit to low-double-digit expected revenue growth and margins supported by service contracts and recurring consumables. The current picture for Agilent is described in public data aggregators as a mix of Buy and Hold ratings, with only a minority recommending Sell.
Focus on consensus ahead of earnings
On a Tuesday, investors often look at consensus numbers as they position ahead of upcoming quarterly earnings releases. For Agilent Technologies, the market typically watches revenue trends in life sciences and chemical analysis and the operating margin as indicators of demand strength.
Consensus models for similar NYSE-listed laboratory equipment groups usually track adjusted earnings per share, free cash flow and year-on-year growth rates by business segment. In the case of Agilent, expectations for the next quarter tend to reflect order trends from pharmaceutical companies, contract research organizations and industrial customers.
All news and data on the Agilent Technologies shares
Background articles, price information and further consensus details on Agilent Technologies can be found in the dedicated topic section.
How Agilent Technologies makes its money
Agilent Technologies generates most of its revenue by providing instruments, consumables and software to laboratories worldwide. Its portfolio includes chromatography systems, spectrometry equipment and related sample preparation tools that are used by pharmaceutical companies, academic institutions and industrial labs.
Where the shares trade today
The Agilent Technologies shares (US00846U1016) trade on the NYSE, with the most recent observable price information indicating an active listing in US dollars. As of 2026-06-30, 11:22, the shares trade in New York in regular-session activity.
Key data on the Agilent Technologies shares
- Company: Agilent Technologies Inc.
- ISIN: US00846U1016
- WKN: 929138
- Ticker: A
- Trading venue: NYSE
- Price (as of 2026-06-30, 11:22): latest observable price in USD
- Market cap: publicly reported multi-billion USD range (as of 2026)
- Sector / industry: Life Sciences Tools & Services / Analytical Instruments
- Index membership: component of broad US equity benchmarks referenced by investors
- Next earnings date: next quarterly release according to the company’s published financial calendar
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data are based on publicly available information believed to be reliable at the time of writing but may change without notice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
